Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14953-4 Xylose^2H post 25 g xylose PO SCnc Bld Pt Qn &nbsp; &nbsp; ACTIVE Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L;nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14953-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Xylose 2h p 25 g Xyl PO Bld-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 120 min; 120 minutes; 120min; 2 hours; 2h p 25 g Xyl PO; After; Blood; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; p 25 g Xyl PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood; Xylose absorption test 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14954-2 Xylose^post dose PO SRat Urine 5H Qn &nbsp; &nbsp; ACTIVE Xylose [Moles/time] in 5 hour Urine --post dose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/5 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 14954-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Xylose p PO 5h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 5 hours; 5.0Hr; 5HR; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; p dose; p PO; PST; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Xylose absorption test 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/(5.h) &nbsp; &nbsp; &nbsp; 0
14955-9 Zinc SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Zinc [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14955-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Zinc SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14956-7 Albumin MRat Urine 24H Qn Detection limit <= 20 mg/L &nbsp; ACTIVE Microalbumin [Mass/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ug/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14956-7 &nbsp; Detection limit <= 20 mg/L &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Microalbumin 24h Ur-mRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/(24.h) &nbsp; &nbsp; &nbsp; 0
14957-5 Albumin MCnc Urine Pt Qn Detection limit <= 20 mg/L &nbsp; ACTIVE Microalbumin [Mass/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/L;mcg/mL; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14957-5 &nbsp; Detection limit <= 20 mg/L &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Microalbumin Ur-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UniversalLabOrders; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mL;mg/dL &nbsp; &nbsp; &nbsp; 0
14958-3 Albumin/Creatinine MRto Urine 24H Qn Detection limit <= 20 mg/L &nbsp; ACTIVE Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/g creatinine &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14958-3 &nbsp; Detection limit <= 20 mg/L &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Microalbumin/Creat 24h Ur &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass concentration ratio; Mass ratio; MCRto; Micro albumin; Microalbumin; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/g{creat} &nbsp; &nbsp; &nbsp; 0
14959-1 Albumin/Creatinine MRto Urine Pt Qn Detection limit <= 20 mg/L &nbsp; ACTIVE Microalbumin/Creatinine [Mass Ratio] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/g creatinine &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14959-1 &nbsp; Detection limit <= 20 mg/L &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Microalbumin/Creat Ur &nbsp; &nbsp; &nbsp; Y &nbsp; Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass concentration ratio; Mass ratio; MCRto; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/g{creat} &nbsp; &nbsp; &nbsp; 0
1496-9 Glucose^1.5H post 75 g glucose PO MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1496-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Glucose 1.5h p 75 g Glc PO SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 1/2 hours; 1 1/2 HR; 1.5h p 75 g Glc PO; 1.5Hr; 75Gm; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
14960-9 Estradiol.free/Estradiol.total MFr Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14960-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Estradiol Free MFr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; 17-beta estradiol; Chemistry; E2; Estradiol Free; Estradiol.non-protein bound; FR; Gyn; Gynecology; Mass Fraction; Non-protein bound; OB; ObGyn; Obstetrics; Oestradiol; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14961-7 Abnormal blood cells.CD10/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD10 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14961-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD10 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Blood; CALLA; CD10 Abn Bld Cells; CD10 Cells; Cell; CELL MARKERS; Cellularity; Common acute lymphoblastic leukemia; Common acute lymphoblastic leukemia antigen; Enkephalinase; gp100; J5; NEP; Neprilysin; Neutral endopeptidase metalloendopeptidase; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14962-5 Abnormal blood cells.CD13/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD13 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14962-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD13 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Aminopeptidase n; APN; Blood; CD13 Abn Bld Cells; CD13 Cells; Cell; CELL MARKERS; Cellularity; gp150; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14963-3 Abnormal blood cells.CD14/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD14 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14963-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD14 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Blood; CD14 Abn Bld Cells; CD14 Cells; Cell; CELL MARKERS; Cellularity; LeuM3; Leu-M3; LPS receptor; LPS-R; Mo2; Mo-2; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14964-1 Abnormal blood cells.CD19/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD19 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14964-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CD19 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Abn Bld Cells; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14965-8 Abnormal blood cells.CD2/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD2 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14965-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD2 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Blood; CD2 Abn Bld Cells; CD2 Cells; CD2R; Cell; CELL MARKERS; Cellularity; E-rosette receptor; Leu5; Leu-5; LFA-2; Lymphocyte-function antigen-2; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T11; Tot; Totl; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14966-6 Abnormal blood cells.CD20/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD20 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14966-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD20 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; B1; B-1; Blood; Bp35; CD20 Abn Bld Cells; CD20 Cells; Cell; CELL MARKERS; Cells.CD20+; Cellularity; Leu16; Leu-16; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14967-4 Abnormal blood cells.CD33/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD33 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14967-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD33 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Blood; CD33 Abn Bld Cells; CD33 Cells; Cell; CELL MARKERS; Cellularity; gp67; LeuM9; Leu-M9; My9; My-9; Number fraction; p67; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14968-2 Abnormal blood cells.CD5/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD5 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14968-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD5 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Blood; CD5 Abn Bld Cells; CD5 Cells; Cell; CELL MARKERS; Cellularity; Leu1; Leu-1; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tot; Totl; Tp67; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14969-0 Abnormal blood cells.CD7/Abnormal blood cells.total NFr Bld Pt Qn &nbsp; &nbsp; ACTIVE CD7 Abnormal blood cells/Abnormal blood cells.total in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CELLMARK &nbsp; 14969-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 CD7 Abn Bld Cells NFr &nbsp; &nbsp; &nbsp; Y &nbsp; abn; abnorm; Blood; CD7 Abn Bld Cells; CD7 Cells; Cell; CELL MARKERS; Cellularity; gp40; Leu9; Leu-9; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T-2; Tot; Totl; TP41; WB; Whole blood 2.7 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
1497-7 Glucose^1.5H post dose insulin IV MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1497-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Glucose 1.5h p Ins IV SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 1/2 hours; 1 1/2 HR; 1.5h p Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
14970-8 Estrone.bioavailable MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14970-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Estrone Bioavail SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; E1; Estrone Bioavail; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
14971-6 Estrone.bioavailable/Estrone.total MFr Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14971-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Estrone Bioavail MFr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; E1; Estrone Bioavail; Gyn; Gynecology; Mass Fraction; OB; ObGyn; Obstetrics; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14972-4 Mycobacterium sp DNA PrThr CSF Pt Ord Probe.amp.tar &nbsp; ACTIVE Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14972-4 &nbsp; Probe.amp.tar &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Mycobacterium DNA CSF Ql NAA+probe &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Myco; Mycobact; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tuberculosis 2.63 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14973-2 Mycobacterium sp DNA PrThr Sputum Pt Ord Probe.amp.tar &nbsp; ACTIVE Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14973-2 &nbsp; Probe.amp.tar &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Mycobacterium DNA Spt Ql NAA+probe &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lower respiratory; Lung; Microbiology; Myco; Mycobact; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; species; spp; Spt; Sputum; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tuberculosis 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14974-0 Mycobacterium sp DNA PrThr XXX Pt Ord Probe.amp.tar &nbsp; ACTIVE Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14974-0 &nbsp; Probe.amp.tar &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Mycobacterium DNA Spec Ql NAA+probe &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Myco; Mycobact; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Tuberculosis; Unspecified 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14975-7 Human antimouse Ab MCnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Human antimouse Ab [Mass/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 14975-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Human Antimouse Ab Ser-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Mouse; Autoantibodies; Autoantibody; HAMA; Human Anti-monoclonal AB; Human anti-mouse Ab; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; 0
108,248 results found